2 Days
Source:
المشهد
Parkinson’s Stem Trial
The world’s first patient to receive stem-cell treatment for Parkinson’s disease underwent the procedure at Kyoto University Hospital in Japan in October, following conditional approval of the treatment. Developed by Sumitomo Pharma, it involves implanting millions of donor-derived cells that are converted into cells capable of producing dopamine in the brain. In a clinical trial involving seven patients, no serious side effects were reported, and four patients’ symptoms improved. The company plans to treat 20 to 30 patients by March 2029, while a decision on final approval is expected after the treatment’s safety and effectiveness have been assessed.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)